SUZUKI Tomohiko

Affiliation

Institute of Medicine

Official title

Professor

ORCID

0000-0001-9722-0373

Email

I+&$&C*,1," t+)":IE$yC+*,",wvCvxC!'P*,1," C+&$&} "&C"w:IE,C+*,",wvCvxC!'

Office

Department of Anatomy and Embryology

Phone

029-853-7516

Research fields

Biological pharmacy

Degree

2005-03	博士（薬学）

Licenses and qualifications

1992-02	薬剤師

Academic societies

2016-09 -- (current)	International Association for the Study of Pain
2012-09 -- (current)	Society for Neuroscience
1996-06 -- (current)	The Japanese Pharmacological Society
1991-09 -- (current)	THE JAPANESE BIOCHEMICAL SOCIETY

Articles

• ez-ADiCon: A novel glyco-remodeling based strategy that enables preparation of homogenous antibody-drug conjugates via one-step enzymatic transglycosylation with payload-preloaded bi-antennary glycan complexes
  Chon Hyongi; Kanamori Satoshi; Hibino Kazuhiro; Nagaha...
  Bioorganic & medicinal chemistry letters/80, 2023-01-15
  
  PubMed
• Anti-pruritic effect of isothiocyanates: Potential involvement of toll-like receptor 3 signaling
  Moriyama Masaki; Konno Mitsuhiro; Serizawa Kanako; Yuz...
  Pharmacology research & perspectives/10(6), 2022-12-01
  
  PubMed
• Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model
  Yokokawa Hiroshi; Higashino Atsunori; Suzuki Saori; Mo...
  Gut/67(2)/pp.372-379, 2018-02-01
  
  PubMed
• Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus
  Tsuge Masataka; Uchida Takuro; Hiraga Nobuhiko; Kan H...
  Antimicrobial agents and chemotherapy/61(6), 2017-06-01
  
  PubMed
• Novel pegylated interferon-β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer
  Iwamura Tomokatsu; Narumi Hideki; Suzuki Tomohiko; Yan...
  Cancer science/108(4)/pp.581-589, 2017-04-01
  
  PubMed
• Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model
  Shimozono Rieko; Nishimura Kazumi; Akiyama Hideo; Funa...
  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research/35(6)/pp.464-473, 2015-06-01
  
  PubMed
• Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain
  Omori Yu; Nakajima Mayumi; Nishimura Kazumi; Takahashi...
  Journal of pharmacological sciences/127(3)/pp.377-381, 2015-03-01
  
  PubMed
• The discovery of potent glycine transporter type-2 inhibitors: design and synthesis of phenoxymethylbenzamide derivatives
  Takahashi Eiki; Arai Tadamasa; Akahira Masato; Nakajim...
  Bioorganic & medicinal chemistry letters/24(18)/pp.4603-4606, 2014-09-15
  
  PubMed
• Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects
  Tanabe Junichi; Izawa Akiko; Takemi Natsumi; Miyauchi ...
  Immunology/122(4)/pp.562-570, 2007-12-01
  
  PubMed
• Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence
  Hasebe Ko; Kawai Koji; Suzuki Tomohiko; Kawamura Kuni...
  Annals of the New York Academy of Sciences/1025/pp.404-413, 2004-10-01
  
  PubMed
• Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents
  Saitoh Akiyoshi; Kimura Yuji; Suzuki Tomohiko; Kawai ...
  Journal of pharmacological sciences/95(3)/pp.374-380, 2004-07-01
  
  PubMed
• Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice
  Takasaki Ichiro; Suzuki Tomohiko; Sasaki Atsushi; Naka...
  The Journal of pharmacology and experimental therapeutics/309(1)/pp.36-41, 2004-04-01
  
  PubMed
• Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions
  Suzuki Tomohiko; Izumimoto Naoki; Takezawa Yuko; Fujim...
  Brain research/995(2)/pp.167-175, 2004-01-09
  
  PubMed
• RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta
  Takayanagi Hiroshi; Kim Sunhwa; Matsuo Koichi; Suzuki ...
  Nature/416(6882)/pp.744-749, 2002-04-18
  
  PubMed
• Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event
  Hirawa N; Uehara Y; Suzuki T; Kawabata Y; Numabe A; ...
  Nephron . 81(2):183-93/81(2)/pp.183-193, 1999-02
  
  PubMed
• Potential role of kallikrein in diurnal rhythms and perivascular distribution in rat pineal glands
  Kudo M; Yamazaki I; Suzuki T; Ebihara Y; Iwadate H; ...
  Brain Res797(2):287-94/797(2)/pp.287-294, 1998-01-29
  
  PubMed
• Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats
  Y Uehara; N Hirawa; Y Kawabata; T Suzuki; N Ohshima; ...
  Hypertension/24(6)/pp.770-778, 1994-12
  
  PubMed
• Tissue kallikrein in rat and mouse neurons
  Kizuki K; Suzuki T; Sugaya K; Noguchi T; Kudo M
  Braz J Med Biol Res/27(8)/pp.1891-1896, 1994-08
  
  PubMed
• Immunohistochemical demonstration of tissue kallikrein in the neurons of rat brain
  Kizuki K; T. Suzuki; Kudo M; Noguchi T
  Brain Res . 1994 Jan 21;634(2):305-9/634(2)/pp.305-309, 1994-01
  
  PubMed

(Last updated: 2024-12-02)